Thousand Oaks, CA, United States of America

Ming Zhang

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovations of Inventor Ming Zhang in Biotherapeutics

Introduction

Ming Zhang, an accomplished inventor based in Thousand Oaks, California, has made significant contributions to the field of biotherapeutics. With a total of four patents to his name, Zhang's work particularly focuses on bispecific proteins that play an important role in immunological responses.

Latest Patents

Among his latest innovations are two notable patents for "Proteins specific for BAFF and B7RP1 and uses thereof." These patents describe bispecific proteins that are tailored to target specific immune-modulating molecules, BAFF and B7RP1. The patents detail the nucleic acids that encode such proteins, methods for their synthesis, and various applications that could enhance therapeutic strategies in treating diseases.

Career Highlights

Ming Zhang is currently employed at Amgen Inc., a leading biotechnology company known for its advancements in pharmaceuticals and biotherapeutics. Throughout his career, Zhang has demonstrated an exceptional ability to innovate, particularly in the development of novel proteins that can significantly impact patient treatment options.

Collaborations

Zhang has collaborated with talented colleagues, including Hailing Hsu and Gunasekaran Kannan, further enriching the research environment at Amgen Inc. These collaborations have likely played a crucial role in his success, bringing diverse expertise to his projects and fostering innovation.

Conclusion

With a robust portfolio of patents and ongoing research in bispecific proteins, Ming Zhang continues to be a driving force in the field of immunotherapy. His innovative work has the potential to pave the way for new therapeutic solutions, enhancing treatment for various immunological conditions and solidifying his standing as a notable inventor in the biopharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…